Century Therapeutics, Inc. (IPSC) earnings
IPSC earnings moved a median of -1.80% by the close. Quarterly and annual IPSC reports and results, each read against the price at its own news timestamp. Back to the IPSC overview →
20 measured IPSC earnings events.
Where these IPSC earnings landedvs 18 measured IPSC earnings reactions
| Middle 50% of IPSC earnings reactions | -5.77% to 0.00% |
|---|---|
| Median reaction (to close) | -1.80% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 IPSC earnings events with a measured close landed between -5.77% and +0.00%; 22% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates | Press release | -0.72% | -5.77% | |
| Form 10-Q Century Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.72% | -5.77% | |
| Form 10-Q Century Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.87% | -0.87% | |
| Form 10-K Century Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.72% | -13.79% | |
| Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -0.09% | — | |
| Form 10-Q Century Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.09% | — | |
| Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -3.68% | -1.99% | |
| Form 10-Q Century Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.68% | -1.99% | |
| Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.17% | +8.23% | |
| Form 10-Q Century Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.17% | +8.23% | |
| Form 10-K Century Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.70% | -4.18% | |
| Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates | Press release | -0.79% | +5.56% | |
| Form 10-Q Century Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.79% | +5.56% | |
| Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates | Press release | +2.22% | +0.00% | |
| Form 10-Q Century Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.22% | +0.00% | |
| Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | +0.00% | -1.62% | |
| Form 10-Q Century Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.62% | |
| Form 10-K Century Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.89% | -6.82% | |
| Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates | Press release | +10.53% | -8.55% | |
| Form 10-Q Century Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +10.53% | -8.55% |
Keep exploring
More IPSC: analyst actions → · SEC filings → · IPSC overview →